Ips Cell-Derived Drug for Parkinson's May Get OK for Health Insurance
- Posted on May 11, 2026
- By The Japan News
- 0 Views
- 1 min read
Ips Cell-Derived Drug for Parkinson's May Get OK for Health Insurance
The Health, Labor and Welfare Ministry will consider whether to cover a medicine derived from induced pluripotent stem cells for the treatment of Parkinson’s disease under the public health insurance scheme, it has been learned.